21 May 2013
Keywords: ligand, pharma, release, promising, results, phase, retinoid
Article | 23 September 1996
- Ligand Pharmaceuticals has released preclinical results of its
retinoid therapy, Tagretin (LGD-1069). The study shows it may be useful
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 September 1996
16 September 1996
20 May 2013
© 2013 thepharmaletter.com